Avobenzone: Chemical UVA Filter Research
Avobenzone (butyl methoxydibenzoylmethane) is the most common UVA filter in US chemical sunscreens. While effective at absorbing UVA radiation, it suffers from significant photostability issues and demonstrates concerning levels of systemic absorption.
Chemical Properties and UV Protection
Avobenzone, marketed as Parsol 1789, is a dibenzoylmethane derivative that absorbs UVA radiation in the 320-400 nm range. It's the only chemical UVA filter approved in the US at concentrations up to 3%, making it essential for broad-spectrum protection in chemical sunscreens.
UV Absorption Spectrum
Avobenzone provides peak absorption at 357 nm, covering the UVA I range (340-400 nm) that penetrates deep into the dermis. This long-wave UVA protection is critical for preventing photoaging, DNA damage, and melanoma. However, avobenzone provides no UVB protection, requiring combination with other filters.
Photostability Challenges
Rapid Photodegradation
Without stabilizers, avobenzone degrades by 50% after just 1 hour of UV exposure, significantly reducing the sunscreen's effectiveness. This photodegradation occurs through keto-enol tautomerization when exposed to UV light, breaking down the molecule and eliminating its protective capacity.
To address instability, manufacturers combine avobenzone with photostabilizers:
- Octocrylene: Most common stabilizer, prevents degradation but adds to chemical load
- Ethylhexyl methoxycrylene: Newer stabilizer with better performance
- Polyester-8: Polymer-based stabilizer reducing skin penetration
- Diethylhexyl syringylidenemalonate: Antioxidant stabilizer
Systemic Absorption Research
FDA Absorption Studies (2019-2020)
FDA clinical trials found avobenzone is absorbed at levels 9 times higher than the agency's safety threshold of 0.5 ng/mL after a single application. Plasma concentrations reached 4.0 ng/mL and remained elevated for days after use stopped.
Key findings from systemic absorption studies:
- Detected in blood within 30 minutes of application
- Accumulates with repeated use over 4 days
- Found in urine samples up to 5 days post-application
- Higher absorption from spray vs. lotion formulations
Safety Concerns
Endocrine Disruption Potential
While less studied than oxybenzone, emerging research suggests avobenzone may have endocrine-disrupting properties. Studies have found it can affect androgen and progesterone receptors, though at lower potency than other chemical filters.
Allergic Reactions
Avobenzone is associated with allergic and photoallergic contact dermatitis. The degradation products formed during photodegradation may be more allergenic than the parent compound, particularly in individuals with sensitive skin.
Environmental Impact
Avobenzone has been detected in surface waters and wastewater treatment plants. While not currently banned like oxybenzone, studies show it can bioaccumulate in aquatic organisms and may contribute to coral bleaching at high concentrations.
Regulatory Status
United States: Approved at up to 3% concentration. FDA has requested additional safety data but has not reached a final determination on GRASE (Generally Recognized As Safe and Effective) status.
European Union: Approved at up to 5% concentration. No current restrictions, though under review for potential endocrine effects.
Other regions: Widely approved globally, though some countries are reviewing safety data in light of absorption studies.
Formulation Considerations
Due to its instability and absorption concerns, avobenzone presents formulation challenges:
- Stabilization requirements: Must be combined with photostabilizers, increasing formula complexity
- Oil solubility: Requires oil phase or solubilizers in water-based formulas
- Incompatibilities: Cannot be formulated with mineral sunscreens (degrades faster)
- Concentration limits: 3% maximum limits UVA protection achievable
Products Tested in Scientific Research
Several commercial products containing avobenzone have been tested in peer-reviewed studies:
FDA Absorption Study Products (2019-2020)
- Coppertone Water Babies SPF 50: Contains 3% avobenzone - showed plasma levels 9x above safety threshold (JAMA 2019;321(21):2082-2091)
View on Amazon - Banana Boat SPF 50+ spray: 3% avobenzone formulation - highest absorption in spray format (JAMA 2020;323(3):256-267)
View on Amazon - Neutrogena Ultra Sheer SPF 55: 3% avobenzone with octocrylene stabilizer - plasma levels remained elevated for days (JAMA 2020;323(3):256-267)
View on Amazon
Photostability Studies
- L'Oréal Ombrelle SPF 60: Avobenzone with Mexoryl stabilizers - 90% retention after 2 hours UV exposure (J Am Acad Dermatol 2008;59(6):882-892)
- La Roche-Posay Anthelios SPF 60: Avobenzone 3% with ecamsule - superior photostability vs. conventional formulas (Photodermatol Photoimmunol Photomed 2010;26(5):216-220)
Combination Product Testing
- Hawaiian Tropic Silk Hydration SPF 30: Avobenzone 2.7% - tested for endocrine activity in vitro (Environ Sci Technol 2016;50(15):8397-8402)
- Aveeno Protect + Hydrate SPF 70: Contains 3% avobenzone with homosalate - high SPF achieved through multiple filters (Int J Pharm 2018;539(1-2):58-64)
Alternatives and Recommendations
For those concerned about avobenzone's absorption and stability issues, alternatives include:
- Zinc oxide: Provides stable, broad-spectrum protection without absorption
- Titanium dioxide + zinc oxide: Combination for full UV coverage
- Newer UVA filters: Mexoryl SX/XL (not available in US) offer better stability
- Physical barriers: Clothing, hats, and shade remain most effective
Given the systemic absorption data and photostability challenges, individuals may want to minimize avobenzone exposure, particularly with daily use products. When using avobenzone-containing sunscreens, reapplication every 2 hours is essential due to photodegradation.